Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin A1c Testing), Technology (Laboratory Testing, Point-of-Care Testing), Application, End-User - Global Forecast 2023-2030
The Hemoglobin Testing Market size was estimated at USD 4.78 billion in 2022 and expected to reach USD 5.21 billion in 2023, at a CAGR 9.36% to reach USD 9.78 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Hemoglobin Testing Market.
- Based on Type, market is studied across Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin A1c Testing, and Hemoglobin Electrophoresis. The Blood Glucose Testing is projected to witness significant market share during forecast period.
- Based on Technology, market is studied across Laboratory Testing and Point-of-Care Testing. The Laboratory Testing is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Anemia Diagnosis & Monitoring, Diabetes Diagnosis & Management, Sickle Cell Disease Screening, and Thalassemia Detection. The Thalassemia Detection is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Diagnostic Laboratories, Homecare Settings, Hospitals & Clinics, and Research Institutes. The Diagnostic Laboratories is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Hemoglobin Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Hemoglobin Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, Agios Pharmaceuticals, Inc., Arkray, Inc., ARUP Laboratories, Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Clarity Diagnostics, LLC, Cliawaived, Inc., Daiichi Biotech Services Sdn. Bhd., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., F. Hoffmann-La Roche AG, HemoCue America by Danaher Corporation, Laboratory Corporation of America Holdings, Masimo Corp., Merck KGaA, PerkinElmer Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Sotera Health Company, Thermo Fisher Scientific Inc., and Versiti, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Hemoglobin Testing Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Hemoglobin Testing Market?
- What is the competitive strategic window for identifying opportunities in the Hemoglobin Testing Market?
- What are the latest technology trends and regulatory frameworks in the Hemoglobin Testing Market?
- What is the market share of the leading vendors in the Hemoglobin Testing Market?
- Which modes and strategic moves are suitable for entering the Hemoglobin Testing Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Hemoglobin Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of chronic diseases and need for regular hemoglobin level monitoring
- 5.1.1.2. Availability of improved and user-friendly point-of-care testing
- 5.1.1.3. Government initiatives promoting awareness about anemia testing
- 5.1.2. Restraints
- 5.1.2.1. Complexity of certain testing methods and need for specialized skills
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in hemoglobin testing methods
- 5.1.3.2. Introduction of high-performing home hemoglobin testing kits and devices
- 5.1.4. Challenges
- 5.1.4.1. Concerns associated with inaccuracy and false positives
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Hemoglobin Testing Market, by Type
- 6.1. Introduction
- 6.2. Blood Glucose Testing
- 6.3. Cyanmethemoglobin Method
- 6.4. Hemoglobin A1c Testing
- 6.5. Hemoglobin Electrophoresis
- 7. Hemoglobin Testing Market, by Technology
- 7.1. Introduction
- 7.2. Laboratory Testing
- 7.3. Point-of-Care Testing
- 8. Hemoglobin Testing Market, by Application
- 8.1. Introduction
- 8.2. Anemia Diagnosis & Monitoring
- 8.3. Diabetes Diagnosis & Management
- 8.4. Sickle Cell Disease Screening
- 8.5. Thalassemia Detection
- 9. Hemoglobin Testing Market, by End-User
- 9.1. Introduction
- 9.2. Diagnostic Laboratories
- 9.3. Homecare Settings
- 9.4. Hospitals & Clinics
- 9.5. Research Institutes
- 10. Americas Hemoglobin Testing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Hemoglobin Testing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Hemoglobin Testing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. ACON Laboratories, Inc.
- 14.1.3. AdvaCare Pharma
- 14.1.4. Agios Pharmaceuticals, Inc.
- 14.1.5. Arkray, Inc.
- 14.1.6. ARUP Laboratories
- 14.1.7. Avantor, Inc.
- 14.1.8. Becton, Dickinson and Company
- 14.1.9. Bio-Rad Laboratories, Inc.
- 14.1.10. Clarity Diagnostics, LLC
- 14.1.11. Cliawaived, Inc.
- 14.1.12. Daiichi Biotech Services Sdn. Bhd.
- 14.1.13. DiaSys Diagnostic Systems GmbH
- 14.1.14. EKF Diagnostics Holdings PLC
- 14.1.15. Epinex Diagnostics Inc.
- 14.1.16. F. Hoffmann-La Roche AG
- 14.1.17. HemoCue America by Danaher Corporation
- 14.1.18. Laboratory Corporation of America Holdings
- 14.1.19. Masimo Corp.
- 14.1.20. Merck KGaA
- 14.1.21. PerkinElmer Inc.
- 14.1.22. Quest Diagnostics Incorporated
- 14.1.23. Siemens Healthcare GmbH
- 14.1.24. Sotera Health Company
- 14.1.25. Thermo Fisher Scientific Inc.
- 14.1.26. Versiti, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook